Cargando…
Reconsidering Aromatase for Breast Cancer Treatment: New Roles for an Old Target
The current therapeutic approach for the treatment of hormone dependent breast cancer includes interference with estrogen receptors via either selective modulators or estrogens deprivation, by preventing their biosynthesis with aromatase inhibitors. Severe side effects and acquired resistance are dr...
Autores principales: | Caciolla, Jessica, Bisi, Alessandra, Belluti, Federica, Rampa, Angela, Gobbi, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696276/ https://www.ncbi.nlm.nih.gov/pubmed/33207783 http://dx.doi.org/10.3390/molecules25225351 |
Ejemplares similares
-
Switching from Aromatase Inhibitors to Dual Targeting Flavonoid-Based Compounds for Breast Cancer Treatment
por: Gobbi, Silvia, et al.
Publicado: (2023) -
Flavonoid-Inspired Vascular Disrupting Agents: Exploring Flavone-8-Acetic Acid and Derivatives in the New Century
por: Gobbi, Silvia, et al.
Publicado: (2021) -
Cardiovascular Profile of Xanthone-Based 1,4 Dihydropyridines Bearing a Lidoflazine Pharmacophore Fragment
por: Bisi, Alessandra, et al.
Publicado: (2018) -
Functionalization of the Chalcone Scaffold for the Discovery of Novel Lead Compounds Targeting Fungal Infections
por: Bonvicini, Francesca, et al.
Publicado: (2019) -
New Coumarin Derivatives as Cholinergic and Cannabinoid System Modulators
por: Montanari, Serena, et al.
Publicado: (2021)